Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trials

Peer Review reports

Original Submission
22 Feb 2023	Submitted	Original manuscript
8 Apr 2023	Reviewed	Reviewer Report
10 Apr 2023	Reviewed	Reviewer Report
15 Apr 2023	Reviewed	Reviewer Report
23 Apr 2023	Reviewed	Reviewer Report
25 Apr 2023	Reviewed	Reviewer Report - Yingshi Zhang
2 May 2023	Author responded	Author comments - Danxue Huang
3 May 2023	Author responded	Author comments - Danxue Huang
Resubmission - Version 2
2 May 2023	Submitted	Manuscript version 2
11 May 2023	Reviewed	Reviewer Report
11 May 2023	Reviewed	Reviewer Report
14 May 2023	Reviewed	Reviewer Report - Yingshi Zhang
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
14 May 2023	Editorially accepted
24 May 2023	Article published	10.1186/s12885-023-10960-w

Back to article page